OR WAIT 15 SECS
March 28, 2017
Insys Therapeutics (Phoenix, AZ) announced that, effective April 17, 2017, Saeed Motahari, will become the Company’s president and chief executive officer and join the company’s Board of Directors. Mr. Motahari joins Insys from Purdue Pharma (stamford, CT), where he served as chief commercial officer from May 2014, leading a successful transformation of the commercial organization as well as contributing to the business development strategy. Prior to Purdue, from 2004-2014 Mr. Motahari worked at Abbott Laboratories and AbbVie, including serving as vice president of US Specialty Brands- New Launches.